Zobrazeno 1 - 10
of 53
pro vyhledávání: '"J L Millar"'
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Benchmarking outcomes across settings commonly requires risk-adjustment for co-morbidities that must be derived from extant sources that were designed for other purposes. A question arises as to the extent to which differing avail
Externí odkaz:
https://doaj.org/article/2ea8bb0ca1f94cee9e54ed61c2403863
Additional file 1 Supplementary Table 1. Quality indicators reported by the PCOR- VIC registry (adapted from [5]). Supplementary Table 2. Charlson Comorbidity Index (CCI) [11]. Supplementary Table 3. Self-report comorbidity questionnaire [12].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f2425d619246241c85c2a7d5d08612
Autor:
J. L. Millar, Ian T. Jones, Michael Chao, Lionel Lim, A. Rezo, Jeremy Shapiro, D. Kipp, Peter Gibbs, Stephen McLaughlin, A. Fong
Publikováno v:
coloproctology. 30:225-233
Die Standardbehandlung eines Rektumkarzinoms wird immer noch von den Ergebnissen randomisierter, klinischer Studien definiert, die den optimalen Zeitpunkt und den Einsatz von adjuvanter Chemotherapie und Bestrahlung im Vergleich mit einer Operation u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea3fe9191a1947e8898d12bc8cfeb10c
https://doi.org/10.1007/s00053-008-8022-9
https://doi.org/10.1007/s00053-008-8022-9
Autor:
T. J. McElwain, J. L. Millar
A pretreatment dose of cyclophosphamide reduced lethality caused by high doses of busulphan or cyclophosphamide. In the case of cyclophosphamide given prior to busulphan, increased survival could be attributed to greater regeneration of haemopoietic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95fc9933b180174062c5cecaa88b6b8a
https://doi.org/10.1159/000401490
https://doi.org/10.1159/000401490
Autor:
Jeremy P.C. Steele, Paul Mitchell, Clive Horton, J. L. Millar, R. D. Clutterbuck, Daniel Catovsky, Ricardo Morilla, Ray Powles
Publikováno v:
Blood. 90:2015-2019
Primary leukemic cells from patients with acute lymphoblastic leukemia (ALL) can be injected intravenously into mice with severe combined immunodeficiency (SCID) to create a model of human leukemia. Leukemic cells disseminate to murine tissues in a c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef5fd9698909a856dfc74d8e71912a29
https://doi.org/10.1182/blood.v90.5.2015
https://doi.org/10.1182/blood.v90.5.2015
Publikováno v:
British Journal of Haematology. 98:119-125
Peripheral blood T cells from 83 patients with multiple myeloma (MM) were examined for the production of interferon-gamma (INF-gamma) and interleukin-2 (IL-2) using three-colour flow cytometry. Comparisons were made between the percentage of cytokine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::976e12ef0b6b0bf227fc8ac5931dd72d
https://doi.org/10.1046/j.1365-2141.1997.1782995.x
https://doi.org/10.1046/j.1365-2141.1997.1782995.x
Publikováno v:
Medical physics. 40(11)
Accurate treatment delivery in high dose rate (HDR) brachytherapy requires correct source dwell positions and dwell times to be administered relative to each other and to the surrounding anatomy. Treatment delivery inaccuracies predominantly occur fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb78ab1884bcc44dee8a96bdd6248b05
https://pubmed.ncbi.nlm.nih.gov/24320414
https://pubmed.ncbi.nlm.nih.gov/24320414
Autor:
C. De Lord, R. D. Clutterbuck, Paul Mitchell, Daniel Catovsky, J. L. Millar, Lynne R. Hiorns, J. Titley, R. L. Powles, Ricardo Morilla
Publikováno v:
Blood. 87:4797-4803
Human interleukin-4 (huIL-4) has been shown to inhibit the growth in vitro of cells from patients with acute lymphoblastic leukemia (ALL). With the aim of determining whether this cytokine might be useful in the treatment of patients with ALL, the ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df17914de8acaaf8931b45597b8c93ae
https://doi.org/10.1182/blood.v87.11.4797.bloodjournal87114797
https://doi.org/10.1182/blood.v87.11.4797.bloodjournal87114797
Autor:
IB Pragnell, Asad Bashey, S. Levi, Christopher J. Marshall, R. D. Clutterbuck, J. L. Millar, R. Gill, Christine J. Farr
Publikováno v:
Europe PubMed Central
The number of steps involved in the pathogenesis of acute myeloid leukemia (AML) is unclear. The initiating event would be expected to exist in all leukemic cells, but subsequent events may be subclonal. If several genetic events occur, they may coop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7502bbb219f0202fd316c234706798
https://doi.org/10.1182/blood.v79.4.981.bloodjournal794981
https://doi.org/10.1182/blood.v79.4.981.bloodjournal794981